USD 24.01
(-3.42%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 | 11.98 Million USD | 30.53% |
2023 | 9.18 Million USD | -41.9% |
2022 | 15.8 Million USD | 10.33% |
2021 | 14.32 Million USD | -39.99% |
2020 | 23.86 Million USD | -26.08% |
2019 | 32.28 Million USD | 40.77% |
2018 | 22.93 Million USD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q4 | 11.98 Million USD | -16.45% |
2024 Q1 | 14.62 Million USD | 59.26% |
2024 Q2 | 15.79 Million USD | 8.06% |
2024 FY | 11.98 Million USD | 30.53% |
2024 Q3 | 14.34 Million USD | -9.22% |
2023 Q1 | 14.35 Million USD | -9.18% |
2023 FY | 9.18 Million USD | -41.9% |
2023 Q4 | 9.18 Million USD | -15.42% |
2023 Q3 | 10.85 Million USD | -13.73% |
2023 Q2 | 12.58 Million USD | -12.33% |
2022 Q4 | 15.8 Million USD | 32.07% |
2022 Q2 | 12.63 Million USD | 1.19% |
2022 FY | 15.8 Million USD | 10.33% |
2022 Q3 | 11.96 Million USD | -5.33% |
2022 Q1 | 12.48 Million USD | -12.79% |
2021 Q3 | 32.6 Million USD | 6.26% |
2021 Q1 | 27.06 Million USD | 13.4% |
2021 FY | 14.32 Million USD | -39.99% |
2021 Q4 | 14.32 Million USD | -56.08% |
2021 Q2 | 30.68 Million USD | 13.39% |
2020 Q4 | 23.86 Million USD | 0.53% |
2020 FY | 23.86 Million USD | -26.08% |
2020 Q3 | 23.73 Million USD | -0.36% |
2020 Q2 | 23.82 Million USD | -37.27% |
2020 Q1 | 37.97 Million USD | 17.63% |
2019 Q4 | 32.28 Million USD | 0.0% |
2019 FY | 32.28 Million USD | 40.77% |
2019 Q1 | - USD | 0.0% |
2018 FY | 22.93 Million USD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
American Well Corporation | 11.78 Million USD | -1.671% |
Doximity, Inc. | 14.54 Million USD | 17.62% |
Evolent Health, Inc. | 644.79 Million USD | 98.142% |
MultiPlan Corporation | 4.56 Billion USD | 99.738% |
Teladoc Health, Inc. | 1.59 Billion USD | 99.247% |
Veeva Systems Inc. | 55.77 Million USD | 78.515% |